started on SPINRAZA
remain on treatment*
*Based on commercial patients in the US (including Puerto Rico) through December 2019.
†Includes clinical trial patients.
‡Clinical studies of SPINRAZA did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger patients.
Sign up with us to receive the latest news, support information, and upcoming events.
SPINRAZA was evaluated in a broad range of SMA types and levels of function
Individual results may vary based on several factors, including severity of disease, initiation of treatment, and duration of therapy.
Watch stories of the potential in individuals treated with SPINRAZA
Your circle of support
Find out how SMA360° can help with insurance and treatment logistics.§
§SMA360° services from Biogen are available only to those who have been prescribed SPINRAZA.
SMA360° is intended for US residents only.